Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

NCT00917293 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

53

Enrollment

INDUSTRY

Sponsor class

Stopped modified formulation under investigation

Conditions

Tardive Dyskinesia

Interventions

DRUG: Pyridoxal 5'-Phosphate
DRUG: Placebo

Sponsor

Medicure